Steve Yoelin M.D. Medical Associates, Inc.
Quick facts
Phase 2 pipeline
- Hyper-Diluted Botox · Aesthetics / Neurology
Hyper-diluted botulinum toxin blocks acetylcholine release at the neuromuscular junction to reduce muscle contractions, potentially at lower concentrations than standard Botox formulations.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Steve Yoelin M.D. Medical Associates, Inc. portfolio CI brief
- Steve Yoelin M.D. Medical Associates, Inc. pipeline updates RSS
Related
- Sector hub: All tracked pharma companies